Showing results (11-20 of 270) with videos related to

Sort By:
Pageof 27
Cancers|February 11, 2023
MET Amplification as a Resistance Driver to TKI Therapies in Lung Cancer: Clinical Challenges and OpportunitiesKang Qin, Lingzhi Hong, Jianjun Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2024
PIKing up and AKTing on Resistance Mutations in Osimertinib-Treated EGFR-Mutated NSCLCNatalie I Vokes, Xiuning Le, Timothy A Yap
Cancer Cell|November 10, 2020
Tumor Mutational Burden as a Pan-cancer Biomarker for Immunotherapy: The Limits and Potential for ConvergenceAntonio Passaro, Albrecht Stenzinger, Solange Peters
Therapeutic Advances in Medical Oncology|March 1, 2021
Current and future treatment options for MET exon 14 skipping alterations in non-small cell lung cancerLingzhi Hong, Jianjun Zhang, John V Heymach, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 8, 2020
Evolving Role of Immunotherapy in Recurrent Metastatic Head and Neck CancerXiuning Le, Renata Ferrarotto, Trisha Wise-Draper, et al.
Targeted Oncology|October 4, 2023
EGFR Tyrosine Kinase Inhibitors for the Treatment of Metastatic Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A PodcastXiuning Le, Eric Nadler, Daniel B Costa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 24, 2023
Antibody-Drug Conjugates in Lung Cancer: Recent Advances and Implementing StrategiesAntonio Passaro, Pasi A Jänne, Solange Peters
Expert Review of Anticancer Therapy|October 18, 2011
Second-line treatment of non-small-cell lung cancer: chemotherapy or tyrosine kinase inhibitors?Antonio Passaro, Enrico Cortesi, Filippo de Marinis
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 2022
Neoadjuvant Chemotherapy Plus Immunotherapy in Early-Stage Resectable Non-Small-Cell Lung CancerAntonio Passaro, Ilaria Attili, Filippo de Marinis
Surgical Oncology Clinics of North America|September 5, 2020
Emerging Therapies in Thoracic Malignancies-Immunotherapy, Targeted Therapy, and T-Cell Therapy in Non-Small Cell Lung CancerBoris Sepesi, Tina Cascone, Stephen G Chun, et al.
Pageof 27